
SPERO THERAPEUTICS INC
SPRONASDAQ๐ #3811 by market capEarnings Aug 12US Equity
$1.22โผ $0.01 (โ1.21%)
Live1hโผ 0.4%
24hโผ 1.2%
7dโผ 3.9%
14dโฒ 1.7%
30dโผ 44.0%
1yโผ 48.2%
๐ฆMarket Cap
$71M
Small Cap
๐Revenue Growth (YoY)
+24.3%
Healthy
๐Gross Margin
100.0%
High
๐ตFCF Margin
13.2%
Healthy
โ๏ธP/S Ratio
1.3x
Cheap
Otter Score
45
Weak
Earnings
Q1 ยท 2026Reported 2026-03-31Earnings Per Share
Actual
-0.13
Expected
-0.18
beat
+29.20%
Revenue
Actual
โ
Expected
โ
โ
โ
Consensus estimates
Recent quarters
Q1 2026
-0.13
beat
Q4 2025
0.53
beat
Q3 2025
-0.13
beat
Q2 2025
-0.03
beat